1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Cell Therapy with Anti-CD19 CAR-NK Cells in Patients with Relapsed or Resistant B-ALLAcute Lymphocytic Leukemia in RelapseNot yet recruitingPhase 1 / Phase 22024-10-08NCT06631040